Close menu




January 28th, 2021 | 10:23 CET

Steinhoff International, AdTiger, NEL: How to realize book profits

  • Investments
Photo credits: pixabay.com

Easy come easy go. That is how private investors feel time and again. Generating book profits is one thing, but securing them in the long term and turning them into a real trading success is quite another. We explain how it can be possible to realize profits with hot stocks, using Steinhoff International, AdTiger and NEL as examples.

time to read: 2 minutes | Author: Nico Popp
ISIN: KYG009701064 , NL0011375019 , NO0010081235

Table of contents:


    Steinhoff International: What gamblers have to endure

    Steinhoff International's stock has been a hot stock for several weeks. Since 2017, the Company has been embroiled in a legal battle. After accounting violations, it rained lawsuits against the Dutch Company with its operational headquarters in South Africa. In total, the lawsuits cover claims amounting to around EUR 8 billion. The Company itself wants to settle these partly in cash and partly in shares in Pepkor. Recently, Pepkor reported quarterly figures. These sent positive signals to gamblers around the penny stock Steinhoff International; if the offer is attractive, the probability of a settlement between the plaintiffs and the furniture group increases. The better the figures at Pepkor, the more likely plaintiffs will also settle with shares in the Company, so the thinking goes.

    But speculation on a settlement is by no means a foregone conclusion. First, there are several plaintiffs, and second, litigation per se is not a suitable environment for investments - too often, there are nasty surprises or an information advantage of professional investors. Yesterday, the Steinhoff share climbed from EUR 0.09 to EUR 0.13 within a few hours, only to correct back below the EUR 0.10 mark. Any gamblers who want to accompany this roller coaster ride should accept such fluctuations at least intraday. The exit should work with fixed limits and directly place these orders after purchasing a share on the market. In this way, the exit is guaranteed and there are no book profits.

    AdTiger: When does this Asian tiger start to jump?

    In contrast to highly hyped gambling stocks, investors can lay the foundation for later success with relatively unknown stocks at entry time. If small companies with an exciting business model can be discovered before the masses, a favorable entry price inevitably results in a lower risk. On the one hand, such stocks have a lower drop height, and, on the other hand, a "safety buffer" is quickly created on the market when more investors become aware of the respective story. The AdTiger share offers just such an investment story.

    The Company sees itself as an advertising platform that helps Chinese advertisers to place ads on the most popular networks. Specifically, AdTiger works with Facebook, Google, Yahoo and also TikTok. In addition to its involvement in China, AdTiger is now looking to India and expects further growth from their vast market. A key to more growth could also be the AdTensor software developed by AdTiger, which uses artificial intelligence and large amounts of data to control and optimize ad campaigns. AdTiger is currently valued at around EUR 80 million and has more than EUR 20 million in cash. As the value is presently trending cautiously sideways, investors can analyze the stock in peace and plan an entry in a considered manner.

    NEL: Here are the decisive marks

    Given the nervous price jumps of their favorite stock, shareholders of the hydrogen pioneer NEL are, at best, capable of deliberate action after the close of trading. Although NEL has gained more than 100% over a three-month period, the warning signals are increasing. Three times in the past four weeks, the stock has gone into reverse beyond the EUR 3.20 mark. Investors sitting on book profits in NEL but still believe in the share's long-term success can reduce part of their risk using partial sales given the large drop in the share price. The chart also provides guidance: While additional selling pressure is to be expected below the EUR 3 mark, the share could pick up speed again beyond the previous high from the beginning of January.


    Conflict of interest

    Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") may in the future hold shares or other financial instruments of the mentioned companies or will bet on rising or falling on rising or falling prices and therefore a conflict of interest may arise in the future. conflict of interest may arise in the future. The Relevant Persons reserve the shares or other financial instruments of the company at any time (hereinafter referred to as the company at any time (hereinafter referred to as a "Transaction"). "Transaction"). Transactions may under certain circumstances influence the respective price of the shares or other financial instruments of the of the Company.

    Furthermore, Apaton Finance GmbH reserves the right to enter into future relationships with the company or with third parties in relation to reports on the company. with regard to reports on the company, which are published within the scope of the Apaton Finance GmbH as well as in the social media, on partner sites or in e-mails, on partner sites or in e-mails. The above references to existing conflicts of interest apply apply to all types and forms of publication used by Apaton Finance GmbH uses for publications on companies.

    Risk notice

    Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and etc. on news.financial. These contents serve information for readers and does not constitute a call to action or recommendations, neither explicitly nor implicitly. implicitly, they are to be understood as an assurance of possible price be understood. The contents do not replace individual professional investment advice and do not constitute an offer to sell the share(s) offer to sell the share(s) or other financial instrument(s) in question, nor is it an nor an invitation to buy or sell such.

    The content is expressly not a financial analysis, but rather financial analysis, but rather journalistic or advertising texts. Readers or users who make investment decisions or carry out transactions on the basis decisions or transactions on the basis of the information provided here act completely at their own risk. There is no contractual relationship between between Apaton Finance GmbH and its readers or the users of its offers. users of its offers, as our information only refers to the company and not to the company, but not to the investment decision of the reader or user. or user.

    The acquisition of financial instruments entails high risks that can lead to the total loss of the capital invested. The information published by Apaton Finance GmbH and its authors are based on careful research on careful research, nevertheless no liability for financial losses financial losses or a content guarantee for topicality, correctness, adequacy and completeness of the contents offered here. contents offered here. Please also note our Terms of use.


    Der Autor

    Nico Popp

    At home in Southern Germany, the passionate stock exchange expert has been accompanying the capital markets for about twenty years. With a soft spot for smaller companies, he is constantly on the lookout for exciting investment stories.

    About the author



    Related comments:

    Commented by Mario Hose on April 14th, 2026 | 07:30 CEST

    Gold Rush Ahead! Nevada Gold at a Bargain Price – Why Lahontan Gold Could Offer the Perfect Entry Opportunity Right Now

    • Mining
    • Gold
    • Commodities
    • geopolitics
    • Investments

    In a world rife with geopolitical tensions, economic uncertainty, and wars in Iran, Ukraine, and other global hotspots, investors are increasingly turning back to the ultimate safe haven: gold. As the price of gold has reached new highs this year, the spotlight is turning to a company operating in one of the world’s most stable mining regions. Lahontan Gold Corp. is on the cusp of a new development phase, supported by a strengthened balance sheet and encouraging project data from Nevada. With the latest success stories from March and a freshly replenished cash reserve, the foundation for a revaluation of the stock has been laid. Those who recognize the signs of the times see here not only a hedge against global crises, but a tangible opportunity for exceptional returns. We offer a detailed analysis of a company that uniquely combines discipline, geology, and market acumen.

    Read

    Commented by Stefan Feulner on April 14th, 2026 | 07:05 CEST

    Why Power Metallic Mines Could Be the Next Billion-Dollar Buyout by the Giants

    • PGMs
    • Commodities
    • Copper
    • geopolitics
    • Investments

    While the world debates the volatility of tech stocks, a perfect storm is brewing in the commodities market. The spotlight is on copper and platinum group metals. With its Nisk project in Québec, Canadian player Power Metallic Mines may have set the course for a new era in Western commodity supply at exactly the right time. With drill results that are unmatched in industry, the company is now coming into the sights of major strategists.

    Read

    Commented by Mario Hose on April 13th, 2026 | 07:30 CEST

    100% Profit Potential in Sight: Vidac Pharma's Chance to Double vs Bayer and Evotec

    • Biotechnology
    • Biotech
    • Pharma
    • Investments

    Even in the spring of 2026, the stock market remains highly volatile. The upheavals caused by geopolitical crises have been and remain significant and ever-present. While heavyweights like Bayer are struggling to shake off their legal baggage and Evotec is steering into calmer waters, a stock from the back row is suddenly stepping into the spotlight. Vidac Pharma has also had a few turbulent months, and this is precisely where experienced investors now sense an opportunity. With a current share price of EUR 0.56, the company is poised for a potential recovery, an uptick, and perhaps even a complete revaluation. If the strategy pays off, the EUR 1 mark could be reached. That would be a chance to double their money for bold investors. But what is behind this optimism? In this report, we take a look at the industry giants and analyze not only them but also why, of all three, the one with the smallest market capitalization could develop the greatest momentum. It is about potential breakthroughs in cancer research and a management team that is optimizing many aspects for success.

    Read